Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma

Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma

Abstract Minimal residual disease (MRD) testing has underpinned the evaluation and expansion of therapeutic options for patients with multiple myeloma (MM). Imaging is essential for evaluating residual disease status, overcoming sampling errors inherent with other MRD modalities. The accuracy of who...

Full description

Saved in:
Bibliographic Details
Main Authors: Christina Messiou, Nuria Porta, Dow-Mu Koh, Angela Riddell, Katherine Downey, James Croft, Leonora Conneely, Georgina Hopkinson, Alina Dragan, Tommy Brown, Simon Stern, Betty Cheung, Charalampia Kyriakou, Pawel Kaczmarek, Kevin Boyd, Charlotte Pawlyn, Jessica Winfield, Martin F. Kaiser
Format: Article
Language:English
Published: Nature Publishing Group 2025-07-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-025-01327-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41408-025-01327-4

Similar Items